Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Urinary Excretion of Acetylamantadine by Cancer Patients

This study has been completed.
Canadian Institutes of Health Research (CIHR)
BioMark Technologies Inc.
Information provided by:
University of Manitoba Identifier:
First received: September 18, 2008
Last updated: NA
Last verified: September 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)